Shanghai Fudan-zhangjiang: Shanghai Fudan Zhangjiang Bio Pharmaceutical : INDICATIVE ANNOUNCEMENT-FDA018 ANTIBODY DRUG CONJUGATE FOR INJECTION RECEIVED THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or...https://www.marketscreener.com/quote/stock/SHANGHAI-FUDAN-ZHANGJIANG-6171207/news/Shanghai-Fudan-Zhangjiang-Bio-Pharmaceutical-nbsp-INDICATIVE-ANNOUNCEMENT-FDA018-ANTIBODY-DRUG-CON-33023127/?utm_medium=RSS&utm_content=20210421